array:24 [
  "pii" => "S1578219015003145"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2016-01-01"
  "aid" => "1211"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2016;107:71-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1003
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 611
      "PDF" => 345
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731015002823"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2015.03.016"
      "estado" => "S300"
      "fechaPublicacion" => "2016-01-01"
      "aid" => "1211"
      "copyright" => "Elsevier España, S.L.U. y AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2016;107:71-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 499
        "formatos" => array:3 [
          "EPUB" => 3
          "HTML" => 362
          "PDF" => 134
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
        "titulo" => "Reacci&#243;n cut&#225;nea mano-pie por regorafenib"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "71"
            "paginaFinal" => "73"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Hand-Foot Skin Reaction to Regorafenib"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 574
                "Ancho" => 990
                "Tamanyo" => 107036
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Eritema y leve descamaci&#243;n en ambas palmas&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "P&#46; Espinosa Lara, C&#46; Bueno Mui&#241;o, B&#46; Doger de Sp&#233;ville, J&#46; Jim&#233;nez Reyes"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Espinosa Lara"
              ]
              1 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Bueno Mui&#241;o"
              ]
              2 => array:2 [
                "nombre" => "B&#46;"
                "apellidos" => "Doger de Sp&#233;ville"
              ]
              3 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Jim&#233;nez Reyes"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015003145"
          "doi" => "10.1016/j.adengl.2015.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003145?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002823?idApp=UINPBA000044"
      "url" => "/00017310/0000010700000001/v1_201512300105/S0001731015002823/v1_201512300105/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1578219015003224"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.11.013"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "1214"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2016;107:73-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 693
      "formatos" => array:3 [
        "EPUB" => 34
        "HTML" => 451
        "PDF" => 208
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Eccrine Carcinoma&#58; The role of Mohs Micrographic Surgery and Review of the Literature"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "73"
          "paginaFinal" => "76"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Carcinoma ductal ecrino&#58; papel de la cirug&#237;a de Mohs y revisi&#243;n de la literatura"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1446
              "Ancho" => 1400
              "Tamanyo" => 372174
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Clinical images&#46; A&#44; Design of the rotation flap on the cheek&#46; B&#44; Result immediately after surgery&#46; Rotation flap and Burow graft&#46; C&#44; Lateral view&#46; Result 45 days after surgery&#46; D&#44; Frontal view&#46; Result 45 days after surgery&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Lorente-Luna, E&#46; Jim&#233;nez Bl&#225;zquez, C&#46; S&#225;nchez Herreros, J&#46; Cuevas Santos"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Lorente-Luna"
            ]
            1 => array:2 [
              "nombre" => "E&#46; Jim&#233;nez"
              "apellidos" => "Bl&#225;zquez"
            ]
            2 => array:2 [
              "nombre" => "C&#46; S&#225;nchez"
              "apellidos" => "Herreros"
            ]
            3 => array:2 [
              "nombre" => "J&#46; Cuevas"
              "apellidos" => "Santos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003224?idApp=UINPBA000044"
    "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003224/v2_201704190205/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219015003157"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.11.006"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "1197"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2016;107:70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1335
      "formatos" => array:3 [
        "EPUB" => 52
        "HTML" => 1040
        "PDF" => 243
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>"
      "titulo" => "My Daughter&#39;s Hair Won&#8217;t Grow"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "70"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "A mi hija no le crece el pelo"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 800
              "Ancho" => 841
              "Tamanyo" => 145087
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "N&#46; Kn&#246;pfel, A&#46; Mart&#237;n-Santiago"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "N&#46;"
              "apellidos" => "Kn&#246;pfel"
            ]
            1 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Mart&#237;n-Santiago"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731015002665"
        "doi" => "10.1016/j.ad.2015.04.015"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002665?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003157?idApp=UINPBA000044"
    "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003157/v2_201704190205/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
    "titulo" => "Hand-Foot Skin Reaction to Regorafenib"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">To the Editor&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "71"
        "paginaFinal" => "73"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P&#46; Espinosa Lara, C&#46; Bueno Mui&#241;o, B&#46; Doger de Sp&#233;ville, J&#46; Jim&#233;nez Reyes"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "P&#46; Espinosa"
            "apellidos" => "Lara"
            "email" => array:1 [
              0 => "pablo&#46;e&#46;lara&#64;outlook&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "C&#46; Bueno"
            "apellidos" => "Mui&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "B&#46; Doger de"
            "apellidos" => "Sp&#233;ville"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "J&#46; Jim&#233;nez"
            "apellidos" => "Reyes"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Unidad de Oncodermatolog&#237;a&#44; Consulta de efectos adversos por antineopl&#225;sicos&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Oncolog&#237;a M&#233;dica&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Reacci&#243;n cut&#225;nea mano-pie por regorafenib"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 574
            "Ancho" => 990
            "Tamanyo" => 103824
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythema and mild desquamation on the palms&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In recent years&#44; the appearance of targeted drugs has revolutionized treatment in the field of oncology&#46; With these drugs&#44; the profile of systemic side effects is different than in conventional chemotherapy and the need for dosage suspension is smaller&#44; but skin reactions are more frequent and often have an effect on adherence&#46; Among these drugs is regorafenib&#44; a multikinase inhibitor that was recently approved for the treatment of metastatic colorectal cancer&#46; The hand-foot skin reaction is one of the most common toxicities of this drug&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">We report the case of a 69-year-old man diagnosed in 2012 with stage <span class="elsevierStyleSmallCaps">IV</span> rectal adenocarcinoma with liver and lung metastases and wild-type K-RAS&#44; for which he had received chemotherapy according to the XELOX-Avastin treatment regimen &#40;capecitabine&#44; oxaliplatin&#44; and bevacizumab&#41;&#44; with progression in the liver after 13 cycles of treatment&#46; He subsequently received treatment with FOLFIRI-Erbitux &#40;irinotecan&#44; 5-fluorouracil&#44; and cetuximab&#41;&#44; with progression in the liver and lungs after 12 cycles&#46; Grade 2 palmar-plantar erythrodysesthesia occurred as a side effect and was initially attributed to the capecitabine treatment&#46; When only residual erythema remained on the palms and soles&#44; the lesions reappeared after the introduction of 5-fluorouracil&#46; The patient also had grade 2 neuropathy&#44; secondary to the oxaliplatin treatment&#44; which persisted at grade 1 at the start of the regorafenib treatment&#46; Two months later&#44; in light of the progression of the disease with FOLFIRI-Erbitux treatment&#44; treatment with regorafenib was started at a dose of 160<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#46; At 2 weeks&#44; the patient reported an increase in erythema on the palms and soles and the appearance of keratotic lesions on the weight-bearing surfaces of both feet &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46; Physical examination revealed poorly defined areas of erythema on the palms&#44; with more intense involvement of the thenar and hypothenar eminences &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#44; and erythema with diffuse desquamation that covered practically the entire surface of both soles&#44; with keratotic papules that were mildly painful to the touch in the weight-bearing areas of the balls of the feet&#44; distributed symmetrically and bilaterally &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46; After diagnosis of regorafenib-induced hand-foot skin reaction&#44; treatment was prescribed with emollients on the palms and soles&#44; as well as curettage and the application of 30&#37; urea to the keratotic regions&#46; Clinical course was good and the pain disappeared&#44; although the erythema persisted&#46; To date&#44; the patient has received 2 cycles of regorafenib&#44; with optimal doses and no need for delays or suspension of treatment&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Regorafenib &#40;Stivarga&#44; Bayer HealthCare Pharmaceuticals&#41; is a new oral multikinase inhibitor<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> that targets cell-signaling pathways involved in angiogenesis &#40;VEGFR1&#8211;3&#44; TIE2&#41;&#44; oncogenesis &#40;KIT&#44; RET&#44; RAF&#41;&#44; and the maintenance of the tumor microenvironment &#40;PDGFR and FGFR&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> It is indicated for the treatment of metastatic colorectal cancer in adult patients who have previously received treatment or are not candidates for other lines of chemotherapy&#44; and in patients with gastrointestinal stromal tumors &#40;GISTs&#41; who are not candidates for surgery and who have not responded to other treatments &#40;imatinib&#44; sunitinib&#41;&#46; Regorafenib is also being investigated for use in other types of cancer&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;3</span></a> The recommended dosage is a single dose of 160<span class="elsevierStyleHsp" style=""></span>mg each day for 3 weeks&#44; followed by 1 week off&#46; Each 4-week period is considered a treatment cycle&#46; Treatment continues as long as it obtains therapeutic benefits or until unacceptable toxicity appears&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Regorafenib was approved for the treatment of metastatic colorectal adenocarcinoma following the publication of the results of a phase <span class="elsevierStyleSmallCaps">iii</span> clinical trial named CORRECT&#44; which compared regorafenib to placebo in patients with colorectal adenocarcinoma whose disease had progressed despite having received the standard antineoplastic therapy&#46; In that study&#44; the most common cutaneous side effect was the hand-foot skin reaction&#44; which affected 46&#46;6&#37; of the 760 randomized patients &#40;16&#46;6&#37; of whom had a grade 3 reaction&#41;<span class="elsevierStyleSup">4</span>&#8211;higher rates than those seen with other multikinase inhibitors such as sorefenib&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> Other common side effects were asthenia &#40;47&#46;7&#37; of patients&#44; 9&#46;2&#37; grade 3&#41;&#44; hypertension &#40;27&#46;8&#37;&#41;&#44; and diarrhea &#40;33&#46;8&#37;&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In a 2013 meta-analysis by Belum et al<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> that included 1078 patients with colorectal adenocarcinoma&#44; GISTs&#44; renal cell carcinoma&#44; and hepatocellular carcinoma who received treatment with regorafenib&#44; the overall incidence of the hand-foot skin reaction was 60&#46;5&#37; &#40;range in the various studies&#44; 46&#46;6&#37;-84&#46;8&#37;&#41;&#46; The lowest incidence &#40;46&#46;6&#37;&#41; was observed in a multicenter phase <span class="elsevierStyleSmallCaps">iii</span> trial with 500 patients with metastatic renal carcinoma&#44; and the highest incidence &#40;84&#46;8&#37;&#41; was reported in a multicenter phase <span class="elsevierStyleSmallCaps">ii</span> trial with 33 patients with GISTs&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The precise molecular mechanism by which the hand-foot skin reaction is caused by multikinase inhibitors such as sorafenib&#8211;or&#44; in our case&#44; regorafenib&#8211;is unknown&#46; According to one hypothesis&#44; a class effect could be caused by direct cytotoxicity of the drug and a defect in cell repair caused by inhibition of PDGFR&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6</span></a> This effect would manifest as very painful and incapacitating hyperkeratotic lesions on pressure or friction points on the palms and soles and would be exacerbated by trauma&#46; The effect is dose-dependent and can be associated with the appearance of edema and blisters &#40;grades 2 and 3&#41;&#46; Histopathologic findings that have been described include epidermal parakeratosis and dyskeratosis with vacuolar degeneration of the keratinocytes&#44; the presence of intracytoplasmic eosinophilic bodies&#44; and blister formation in the Malpighian layer&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6</span></a> A dense superficial and perivascular lymphocytic inflammatory infiltrate with some degree of nonleukocytoclastic vasculitis is observed in the dermis&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> Treatment consists of keratolytic agents &#40;30&#37;-40&#37; urea&#44; salicylic acid&#41; plus prophylactic measures &#40;preventive offloading with adapted orthopedic insoles&#44; podiatric care&#44; etc&#46;&#41;&#44; and analgesia&#46; Early introduction of these measures can help make it possible to maintain antineoplastic therapy at optimal doses and prevent delays or withdrawal of treatment&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7&#44;8</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">It is important to differentiate this effect from hand-foot syndrome&#44; also known as palmar-plantar erythrodysesthesia or chemotherapy-induced acral erythema &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> This syndrome appears in patients who receive conventional chemotherapy such as liposomal doxorubicin&#44; capecitabine&#44; or cytarabine and is associated with erythema&#44; variable desquamation and edema&#44; and even fissuring and blistering&#46; Both entities are dose-dependent&#44; and in both cases cytotoxicity is the most likely pathophysiological mechanism&#46; In the hand-foot skin reaction&#44; however&#44; hyperkeratosis is more frequent&#44; appears earlier&#44; is patchier&#44; and can be the only manifestation&#46;<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6&#44;10</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">This is the first case of hand-foot skin reaction secondary to regorafenib to be reported in the Spanish medical literature&#46; Dermatologists should be aware of this entity and be able to diagnose it as part of the multidisciplinary management of the cutaneous side effects of new antineoplastic drugs&#44; because managing these effects is important to ensuring adherence to treatment and optimizing the clinical response to therapy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Lara PE&#44; Mui&#241;o CB&#44; Sp&#233;ville BDd&#44; Reyes JJ&#46; Reacci&#243;n cut&#225;nea mano-pie por regorafenib&#46; Actas Dermosifiliogr&#46; 2016&#59;107&#58;70&#8211;72&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 574
            "Ancho" => 990
            "Tamanyo" => 103824
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythema and mild desquamation on the palms&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1072
            "Ancho" => 990
            "Tamanyo" => 227897
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hyperkeratotic papules on weight-bearing surfaces of the balls of the feet&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "Source&#58; Adapted from V&#46; Sanz Motilva&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>"
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hand-Foot Syndrome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hand-Foot Skin Reaction&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Causative agents&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Conventional chemotherapy &#40;5-fluorouracil and derivatives&#44; cytarabine&#44; liposomal doxorubicin&#44; etc&#46;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Multikinase inhibitors &#40;sorafenib&#44; sunitinib&#44; vemurafenib&#44; dabrafenib&#44; regorafenib&#44; etc&#46;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Clinical manifestations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Diffuse erythema and edema&#44; fissures&#44; desquamation&#44; and blisters&#46; Symmetrical&#46; Worsens over time&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Erythematous papules and plaques with a peripheral halo in areas of pressure or friction&#46; Marked hyperkeratosis&#46; Improves over time&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose dependence&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Yes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Yes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Histopathology&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interface dermatitis&#46;<br>Variable edema&#46;<br>Epidermal detachment&#46;<br>Epidermal dysmaturation&#46;<br>Necrotic keratinocytes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>eccrine squamous syringometaplasia&#46;<br>Mild inflammatory infiltrate&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Epidermal hyperplasia&#46;<br>Acanthosis&#44; hyperkeratosis&#44; and focal parakeratosis&#46;<br>Intraepidermal edema&#46;<br>Necrotic keratinocytes&#46;<br>Interface dermatitis&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1396707.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hand-Foot Syndrome vs Hand-Foot Skin Reaction&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Regorafenib &#40;BAY 73-4506&#41;&#58; A new oral multikinase inhibitor of angiogenic&#44; stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;M&#46; Wilhelm"
                            1 => "J&#46; Dumas"
                            2 => "L&#46; Adnane"
                            3 => "M&#46; Lynch"
                            4 => "C&#46;A&#46; Carter"
                            5 => "G&#46; Sch&#252;tz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int J Cancer J Int Cancer&#46;"
                        "fecha" => "2011"
                        "volumen" => "129"
                        "paginaInicial" => "245"
                        "paginaFinal" => "255"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Medicines Agency&#46; Stivarga &#40;regorafenib&#41; &#91;Internet&#93; htttp&#58;&#47;&#47;www&#46;ema&#46;europa&#46;eu&#47;ema&#47;index&#46;jsp&#63;curl&#61;pages&#47;medicines&#47;human&#47;medicines&#47;002573&#47;human&#95;med&#95;001684&#46;jsp&#8739;&#61;WC0b01ac058001d124&#46; Accessed November 21&#44; 2014&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib&#58; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "V&#46;R&#46; Belum"
                            1 => "S&#46; Wu"
                            2 => "M&#46;E&#46; Lacouture"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10637-013-9977-0"
                      "Revista" => array:7 [
                        "tituloSerie" => "Invest New Drugs&#46;"
                        "fecha" => "2013"
                        "volumen" => "31"
                        "paginaInicial" => "1078"
                        "paginaFinal" => "1086"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23700287"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109704000038"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Regorafenib monotherapy for previously treated metastatic colorectal cancer &#40;CORRECT&#41;&#58; An international&#44; multicentre&#44; randomised&#44; placebo-controlled&#44; phase 3 trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Grothey"
                            1 => "E&#46; van Cutsem"
                            2 => "A&#46; Sobrero"
                            3 => "S&#46; Siena"
                            4 => "A&#46; Falcone"
                            5 => "M&#46; Ychou"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(12)61900-X"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2013"
                        "volumen" => "381"
                        "paginaInicial" => "303"
                        "paginaFinal" => "312"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23177514"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective study of the cutaneous adverse effects of sorafenib&#44; a novel multikinase inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Autier"
                            1 => "B&#46; Escudier"
                            2 => "J&#46; Wechsler"
                            3 => "A&#46; Spatz"
                            4 => "C&#46; Robert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archderm.144.7.886"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol&#46;"
                        "fecha" => "2008"
                        "volumen" => "144"
                        "paginaInicial" => "886"
                        "paginaFinal" => "892"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18645140"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reacci&#243;n cut&#225;nea palmoplantar secundaria a sorafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Echeverr&#237;a"
                            1 => "B&#46; Llombart"
                            2 => "R&#46; Botella-Estrada"
                            3 => "C&#46; Guill&#233;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermo-Sifiliogr&#225;ficas&#46;"
                        "fecha" => "2009"
                        "volumen" => "100"
                        "paginaInicial" => "736"
                        "paginaFinal" => "737"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19775561"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention and management of adverse events related to regorafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; De Wit"
                            1 => "C&#46;B&#46; Boers-Doets"
                            2 => "A&#46; Saettini"
                            3 => "K&#46; Vermeersch"
                            4 => "C&#46;R&#46; de Juan"
                            5 => "J&#46; Ouwerkerk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00520-013-2085-z"
                      "Revista" => array:6 [
                        "tituloSerie" => "Support Care Cancer&#46;"
                        "fecha" => "2014"
                        "volumen" => "22"
                        "paginaInicial" => "837"
                        "paginaFinal" => "846"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24337717"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:7 [
                            0 => "J&#46; Sastre"
                            1 => "G&#46; Argil&#233;s"
                            2 => "M&#46; Benavides"
                            3 => "M&#46; Benavides"
                            4 => "J&#46; Feli&#250;"
                            5 => "P&#46; Garc&#237;a-Alfonso"
                            6 => "R&#46; Garc&#237;a-Carbonero"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12094-014-1212-8"
                      "Revista" => array:7 [
                        "tituloSerie" => "Clin Transl Oncol&#46;"
                        "fecha" => "2014"
                        "volumen" => "16"
                        "paginaInicial" => "942"
                        "paginaFinal" => "953"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25223744"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109703014049"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Sanz Motilva V&#46; Patolog&#237;a Cut&#225;nea en paciente sometido a terapias frente a dianas moleculares&#46; Simposio&#46; Introducci&#243;n a la dermatonocolog&#237;a&#46; 41 Congreso Nacional de la Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a &#40;AEDV&#41;&#46; Valencia&#44; June 5-8&#44; 2013&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Chemotherapy-induced acral erythema&#58; A clinical and histopathologic study of 44 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Hueso"
                            1 => "O&#46; Sanmart&#237;n"
                            2 => "E&#46; Nagore"
                            3 => "R&#46; Botella-Estrada"
                            4 => "C&#46; Requena"
                            5 => "B&#46; Llombart"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermo-Sifiliogr&#225;ficas&#46;"
                        "fecha" => "2008"
                        "volumen" => "99"
                        "paginaInicial" => "281"
                        "paginaFinal" => "290"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18394404"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003145/v2_201704190205/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010700000001/v2_201704190205/S1578219015003145/v2_201704190205/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003145?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Case and Research Letters
Hand-Foot Skin Reaction to Regorafenib
Reacción cutánea mano-pie por regorafenib
P. Espinosa Laraa,
Corresponding author
pablo.e.lara@outlook.es

Corresponding author.
, C. Bueno Muiñob, B. Doger de Spévilleb, J. Jiménez Reyesc
a Servicio de Dermatología, Unidad de Oncodermatología, Consulta de efectos adversos por antineoplásicos, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain
b Servicio de Oncología Médica, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain
c Servicio de Dermatología, Hospital Universitario Infanta Cristina, Parla, Madrid, Spain
Read
6843
Times
was read the article
2315
Total PDF
4528
Total HTML
Share statistics
 array:24 [
  "pii" => "S1578219015003145"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2016-01-01"
  "aid" => "1211"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2016;107:71-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1003
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 611
      "PDF" => 345
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731015002823"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2015.03.016"
      "estado" => "S300"
      "fechaPublicacion" => "2016-01-01"
      "aid" => "1211"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; y AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2016;107:71-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 499
        "formatos" => array:3 [
          "EPUB" => 3
          "HTML" => 362
          "PDF" => 134
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENT&#205;FICO-CL&#205;NICA</span>"
        "titulo" => "Reacci&#243;n cut&#225;nea mano-pie por regorafenib"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "71"
            "paginaFinal" => "73"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Hand-Foot Skin Reaction to Regorafenib"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 574
                "Ancho" => 990
                "Tamanyo" => 107036
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Eritema y leve descamaci&#243;n en ambas palmas&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "P&#46; Espinosa Lara, C&#46; Bueno Mui&#241;o, B&#46; Doger de Sp&#233;ville, J&#46; Jim&#233;nez Reyes"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Espinosa Lara"
              ]
              1 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Bueno Mui&#241;o"
              ]
              2 => array:2 [
                "nombre" => "B&#46;"
                "apellidos" => "Doger de Sp&#233;ville"
              ]
              3 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Jim&#233;nez Reyes"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015003145"
          "doi" => "10.1016/j.adengl.2015.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003145?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002823?idApp=UINPBA000044"
      "url" => "/00017310/0000010700000001/v1_201512300105/S0001731015002823/v1_201512300105/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1578219015003224"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.11.013"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "1214"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2016;107:73-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 693
      "formatos" => array:3 [
        "EPUB" => 34
        "HTML" => 451
        "PDF" => 208
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Eccrine Carcinoma&#58; The role of Mohs Micrographic Surgery and Review of the Literature"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "73"
          "paginaFinal" => "76"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Carcinoma ductal ecrino&#58; papel de la cirug&#237;a de Mohs y revisi&#243;n de la literatura"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1446
              "Ancho" => 1400
              "Tamanyo" => 372174
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Clinical images&#46; A&#44; Design of the rotation flap on the cheek&#46; B&#44; Result immediately after surgery&#46; Rotation flap and Burow graft&#46; C&#44; Lateral view&#46; Result 45 days after surgery&#46; D&#44; Frontal view&#46; Result 45 days after surgery&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Lorente-Luna, E&#46; Jim&#233;nez Bl&#225;zquez, C&#46; S&#225;nchez Herreros, J&#46; Cuevas Santos"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Lorente-Luna"
            ]
            1 => array:2 [
              "nombre" => "E&#46; Jim&#233;nez"
              "apellidos" => "Bl&#225;zquez"
            ]
            2 => array:2 [
              "nombre" => "C&#46; S&#225;nchez"
              "apellidos" => "Herreros"
            ]
            3 => array:2 [
              "nombre" => "J&#46; Cuevas"
              "apellidos" => "Santos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003224?idApp=UINPBA000044"
    "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003224/v2_201704190205/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219015003157"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.11.006"
    "estado" => "S300"
    "fechaPublicacion" => "2016-01-01"
    "aid" => "1197"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Actas Dermosifiliogr. 2016;107:70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1335
      "formatos" => array:3 [
        "EPUB" => 52
        "HTML" => 1040
        "PDF" => 243
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>"
      "titulo" => "My Daughter&#39;s Hair Won&#8217;t Grow"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "70"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "A mi hija no le crece el pelo"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 800
              "Ancho" => 841
              "Tamanyo" => 145087
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "N&#46; Kn&#246;pfel, A&#46; Mart&#237;n-Santiago"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "N&#46;"
              "apellidos" => "Kn&#246;pfel"
            ]
            1 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Mart&#237;n-Santiago"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731015002665"
        "doi" => "10.1016/j.ad.2015.04.015"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731015002665?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003157?idApp=UINPBA000044"
    "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003157/v2_201704190205/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
    "titulo" => "Hand-Foot Skin Reaction to Regorafenib"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">To the Editor&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "71"
        "paginaFinal" => "73"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P&#46; Espinosa Lara, C&#46; Bueno Mui&#241;o, B&#46; Doger de Sp&#233;ville, J&#46; Jim&#233;nez Reyes"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "P&#46; Espinosa"
            "apellidos" => "Lara"
            "email" => array:1 [
              0 => "pablo&#46;e&#46;lara&#64;outlook&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "C&#46; Bueno"
            "apellidos" => "Mui&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "B&#46; Doger de"
            "apellidos" => "Sp&#233;ville"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "J&#46; Jim&#233;nez"
            "apellidos" => "Reyes"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Unidad de Oncodermatolog&#237;a&#44; Consulta de efectos adversos por antineopl&#225;sicos&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Oncolog&#237;a M&#233;dica&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario Infanta Cristina&#44; Parla&#44; Madrid&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Reacci&#243;n cut&#225;nea mano-pie por regorafenib"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 574
            "Ancho" => 990
            "Tamanyo" => 103824
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythema and mild desquamation on the palms&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In recent years&#44; the appearance of targeted drugs has revolutionized treatment in the field of oncology&#46; With these drugs&#44; the profile of systemic side effects is different than in conventional chemotherapy and the need for dosage suspension is smaller&#44; but skin reactions are more frequent and often have an effect on adherence&#46; Among these drugs is regorafenib&#44; a multikinase inhibitor that was recently approved for the treatment of metastatic colorectal cancer&#46; The hand-foot skin reaction is one of the most common toxicities of this drug&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">We report the case of a 69-year-old man diagnosed in 2012 with stage <span class="elsevierStyleSmallCaps">IV</span> rectal adenocarcinoma with liver and lung metastases and wild-type K-RAS&#44; for which he had received chemotherapy according to the XELOX-Avastin treatment regimen &#40;capecitabine&#44; oxaliplatin&#44; and bevacizumab&#41;&#44; with progression in the liver after 13 cycles of treatment&#46; He subsequently received treatment with FOLFIRI-Erbitux &#40;irinotecan&#44; 5-fluorouracil&#44; and cetuximab&#41;&#44; with progression in the liver and lungs after 12 cycles&#46; Grade 2 palmar-plantar erythrodysesthesia occurred as a side effect and was initially attributed to the capecitabine treatment&#46; When only residual erythema remained on the palms and soles&#44; the lesions reappeared after the introduction of 5-fluorouracil&#46; The patient also had grade 2 neuropathy&#44; secondary to the oxaliplatin treatment&#44; which persisted at grade 1 at the start of the regorafenib treatment&#46; Two months later&#44; in light of the progression of the disease with FOLFIRI-Erbitux treatment&#44; treatment with regorafenib was started at a dose of 160<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#46; At 2 weeks&#44; the patient reported an increase in erythema on the palms and soles and the appearance of keratotic lesions on the weight-bearing surfaces of both feet &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46; Physical examination revealed poorly defined areas of erythema on the palms&#44; with more intense involvement of the thenar and hypothenar eminences &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#44; and erythema with diffuse desquamation that covered practically the entire surface of both soles&#44; with keratotic papules that were mildly painful to the touch in the weight-bearing areas of the balls of the feet&#44; distributed symmetrically and bilaterally &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46; After diagnosis of regorafenib-induced hand-foot skin reaction&#44; treatment was prescribed with emollients on the palms and soles&#44; as well as curettage and the application of 30&#37; urea to the keratotic regions&#46; Clinical course was good and the pain disappeared&#44; although the erythema persisted&#46; To date&#44; the patient has received 2 cycles of regorafenib&#44; with optimal doses and no need for delays or suspension of treatment&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Regorafenib &#40;Stivarga&#44; Bayer HealthCare Pharmaceuticals&#41; is a new oral multikinase inhibitor<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> that targets cell-signaling pathways involved in angiogenesis &#40;VEGFR1&#8211;3&#44; TIE2&#41;&#44; oncogenesis &#40;KIT&#44; RET&#44; RAF&#41;&#44; and the maintenance of the tumor microenvironment &#40;PDGFR and FGFR&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> It is indicated for the treatment of metastatic colorectal cancer in adult patients who have previously received treatment or are not candidates for other lines of chemotherapy&#44; and in patients with gastrointestinal stromal tumors &#40;GISTs&#41; who are not candidates for surgery and who have not responded to other treatments &#40;imatinib&#44; sunitinib&#41;&#46; Regorafenib is also being investigated for use in other types of cancer&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#44;3</span></a> The recommended dosage is a single dose of 160<span class="elsevierStyleHsp" style=""></span>mg each day for 3 weeks&#44; followed by 1 week off&#46; Each 4-week period is considered a treatment cycle&#46; Treatment continues as long as it obtains therapeutic benefits or until unacceptable toxicity appears&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Regorafenib was approved for the treatment of metastatic colorectal adenocarcinoma following the publication of the results of a phase <span class="elsevierStyleSmallCaps">iii</span> clinical trial named CORRECT&#44; which compared regorafenib to placebo in patients with colorectal adenocarcinoma whose disease had progressed despite having received the standard antineoplastic therapy&#46; In that study&#44; the most common cutaneous side effect was the hand-foot skin reaction&#44; which affected 46&#46;6&#37; of the 760 randomized patients &#40;16&#46;6&#37; of whom had a grade 3 reaction&#41;<span class="elsevierStyleSup">4</span>&#8211;higher rates than those seen with other multikinase inhibitors such as sorefenib&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> Other common side effects were asthenia &#40;47&#46;7&#37; of patients&#44; 9&#46;2&#37; grade 3&#41;&#44; hypertension &#40;27&#46;8&#37;&#41;&#44; and diarrhea &#40;33&#46;8&#37;&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In a 2013 meta-analysis by Belum et al<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> that included 1078 patients with colorectal adenocarcinoma&#44; GISTs&#44; renal cell carcinoma&#44; and hepatocellular carcinoma who received treatment with regorafenib&#44; the overall incidence of the hand-foot skin reaction was 60&#46;5&#37; &#40;range in the various studies&#44; 46&#46;6&#37;-84&#46;8&#37;&#41;&#46; The lowest incidence &#40;46&#46;6&#37;&#41; was observed in a multicenter phase <span class="elsevierStyleSmallCaps">iii</span> trial with 500 patients with metastatic renal carcinoma&#44; and the highest incidence &#40;84&#46;8&#37;&#41; was reported in a multicenter phase <span class="elsevierStyleSmallCaps">ii</span> trial with 33 patients with GISTs&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The precise molecular mechanism by which the hand-foot skin reaction is caused by multikinase inhibitors such as sorafenib&#8211;or&#44; in our case&#44; regorafenib&#8211;is unknown&#46; According to one hypothesis&#44; a class effect could be caused by direct cytotoxicity of the drug and a defect in cell repair caused by inhibition of PDGFR&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6</span></a> This effect would manifest as very painful and incapacitating hyperkeratotic lesions on pressure or friction points on the palms and soles and would be exacerbated by trauma&#46; The effect is dose-dependent and can be associated with the appearance of edema and blisters &#40;grades 2 and 3&#41;&#46; Histopathologic findings that have been described include epidermal parakeratosis and dyskeratosis with vacuolar degeneration of the keratinocytes&#44; the presence of intracytoplasmic eosinophilic bodies&#44; and blister formation in the Malpighian layer&#46;<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">5&#44;6</span></a> A dense superficial and perivascular lymphocytic inflammatory infiltrate with some degree of nonleukocytoclastic vasculitis is observed in the dermis&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> Treatment consists of keratolytic agents &#40;30&#37;-40&#37; urea&#44; salicylic acid&#41; plus prophylactic measures &#40;preventive offloading with adapted orthopedic insoles&#44; podiatric care&#44; etc&#46;&#41;&#44; and analgesia&#46; Early introduction of these measures can help make it possible to maintain antineoplastic therapy at optimal doses and prevent delays or withdrawal of treatment&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7&#44;8</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">It is important to differentiate this effect from hand-foot syndrome&#44; also known as palmar-plantar erythrodysesthesia or chemotherapy-induced acral erythema &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> This syndrome appears in patients who receive conventional chemotherapy such as liposomal doxorubicin&#44; capecitabine&#44; or cytarabine and is associated with erythema&#44; variable desquamation and edema&#44; and even fissuring and blistering&#46; Both entities are dose-dependent&#44; and in both cases cytotoxicity is the most likely pathophysiological mechanism&#46; In the hand-foot skin reaction&#44; however&#44; hyperkeratosis is more frequent&#44; appears earlier&#44; is patchier&#44; and can be the only manifestation&#46;<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">6&#44;10</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">This is the first case of hand-foot skin reaction secondary to regorafenib to be reported in the Spanish medical literature&#46; Dermatologists should be aware of this entity and be able to diagnose it as part of the multidisciplinary management of the cutaneous side effects of new antineoplastic drugs&#44; because managing these effects is important to ensuring adherence to treatment and optimizing the clinical response to therapy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Lara PE&#44; Mui&#241;o CB&#44; Sp&#233;ville BDd&#44; Reyes JJ&#46; Reacci&#243;n cut&#225;nea mano-pie por regorafenib&#46; Actas Dermosifiliogr&#46; 2016&#59;107&#58;70&#8211;72&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 574
            "Ancho" => 990
            "Tamanyo" => 103824
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythema and mild desquamation on the palms&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1072
            "Ancho" => 990
            "Tamanyo" => 227897
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hyperkeratotic papules on weight-bearing surfaces of the balls of the feet&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "Source&#58; Adapted from V&#46; Sanz Motilva&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>"
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hand-Foot Syndrome&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hand-Foot Skin Reaction&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Causative agents&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Conventional chemotherapy &#40;5-fluorouracil and derivatives&#44; cytarabine&#44; liposomal doxorubicin&#44; etc&#46;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Multikinase inhibitors &#40;sorafenib&#44; sunitinib&#44; vemurafenib&#44; dabrafenib&#44; regorafenib&#44; etc&#46;&#41;&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Clinical manifestations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Diffuse erythema and edema&#44; fissures&#44; desquamation&#44; and blisters&#46; Symmetrical&#46; Worsens over time&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Erythematous papules and plaques with a peripheral halo in areas of pressure or friction&#46; Marked hyperkeratosis&#46; Improves over time&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose dependence&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Yes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Yes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Histopathology&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interface dermatitis&#46;<br>Variable edema&#46;<br>Epidermal detachment&#46;<br>Epidermal dysmaturation&#46;<br>Necrotic keratinocytes<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>eccrine squamous syringometaplasia&#46;<br>Mild inflammatory infiltrate&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Epidermal hyperplasia&#46;<br>Acanthosis&#44; hyperkeratosis&#44; and focal parakeratosis&#46;<br>Intraepidermal edema&#46;<br>Necrotic keratinocytes&#46;<br>Interface dermatitis&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1396707.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hand-Foot Syndrome vs Hand-Foot Skin Reaction&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Regorafenib &#40;BAY 73-4506&#41;&#58; A new oral multikinase inhibitor of angiogenic&#44; stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46;M&#46; Wilhelm"
                            1 => "J&#46; Dumas"
                            2 => "L&#46; Adnane"
                            3 => "M&#46; Lynch"
                            4 => "C&#46;A&#46; Carter"
                            5 => "G&#46; Sch&#252;tz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Int J Cancer J Int Cancer&#46;"
                        "fecha" => "2011"
                        "volumen" => "129"
                        "paginaInicial" => "245"
                        "paginaFinal" => "255"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "European Medicines Agency&#46; Stivarga &#40;regorafenib&#41; &#91;Internet&#93; htttp&#58;&#47;&#47;www&#46;ema&#46;europa&#46;eu&#47;ema&#47;index&#46;jsp&#63;curl&#61;pages&#47;medicines&#47;human&#47;medicines&#47;002573&#47;human&#95;med&#95;001684&#46;jsp&#8739;&#61;WC0b01ac058001d124&#46; Accessed November 21&#44; 2014&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib&#58; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "V&#46;R&#46; Belum"
                            1 => "S&#46; Wu"
                            2 => "M&#46;E&#46; Lacouture"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10637-013-9977-0"
                      "Revista" => array:7 [
                        "tituloSerie" => "Invest New Drugs&#46;"
                        "fecha" => "2013"
                        "volumen" => "31"
                        "paginaInicial" => "1078"
                        "paginaFinal" => "1086"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23700287"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109704000038"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Regorafenib monotherapy for previously treated metastatic colorectal cancer &#40;CORRECT&#41;&#58; An international&#44; multicentre&#44; randomised&#44; placebo-controlled&#44; phase 3 trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Grothey"
                            1 => "E&#46; van Cutsem"
                            2 => "A&#46; Sobrero"
                            3 => "S&#46; Siena"
                            4 => "A&#46; Falcone"
                            5 => "M&#46; Ychou"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(12)61900-X"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet&#46;"
                        "fecha" => "2013"
                        "volumen" => "381"
                        "paginaInicial" => "303"
                        "paginaFinal" => "312"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23177514"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective study of the cutaneous adverse effects of sorafenib&#44; a novel multikinase inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46; Autier"
                            1 => "B&#46; Escudier"
                            2 => "J&#46; Wechsler"
                            3 => "A&#46; Spatz"
                            4 => "C&#46; Robert"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archderm.144.7.886"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol&#46;"
                        "fecha" => "2008"
                        "volumen" => "144"
                        "paginaInicial" => "886"
                        "paginaFinal" => "892"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18645140"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reacci&#243;n cut&#225;nea palmoplantar secundaria a sorafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Echeverr&#237;a"
                            1 => "B&#46; Llombart"
                            2 => "R&#46; Botella-Estrada"
                            3 => "C&#46; Guill&#233;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermo-Sifiliogr&#225;ficas&#46;"
                        "fecha" => "2009"
                        "volumen" => "100"
                        "paginaInicial" => "736"
                        "paginaFinal" => "737"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19775561"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention and management of adverse events related to regorafenib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; De Wit"
                            1 => "C&#46;B&#46; Boers-Doets"
                            2 => "A&#46; Saettini"
                            3 => "K&#46; Vermeersch"
                            4 => "C&#46;R&#46; de Juan"
                            5 => "J&#46; Ouwerkerk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00520-013-2085-z"
                      "Revista" => array:6 [
                        "tituloSerie" => "Support Care Cancer&#46;"
                        "fecha" => "2014"
                        "volumen" => "22"
                        "paginaInicial" => "837"
                        "paginaFinal" => "846"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24337717"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:7 [
                            0 => "J&#46; Sastre"
                            1 => "G&#46; Argil&#233;s"
                            2 => "M&#46; Benavides"
                            3 => "M&#46; Benavides"
                            4 => "J&#46; Feli&#250;"
                            5 => "P&#46; Garc&#237;a-Alfonso"
                            6 => "R&#46; Garc&#237;a-Carbonero"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12094-014-1212-8"
                      "Revista" => array:7 [
                        "tituloSerie" => "Clin Transl Oncol&#46;"
                        "fecha" => "2014"
                        "volumen" => "16"
                        "paginaInicial" => "942"
                        "paginaFinal" => "953"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25223744"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109703014049"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Sanz Motilva V&#46; Patolog&#237;a Cut&#225;nea en paciente sometido a terapias frente a dianas moleculares&#46; Simposio&#46; Introducci&#243;n a la dermatonocolog&#237;a&#46; 41 Congreso Nacional de la Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a &#40;AEDV&#41;&#46; Valencia&#44; June 5-8&#44; 2013&#46;"
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Chemotherapy-induced acral erythema&#58; A clinical and histopathologic study of 44 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Hueso"
                            1 => "O&#46; Sanmart&#237;n"
                            2 => "E&#46; Nagore"
                            3 => "R&#46; Botella-Estrada"
                            4 => "C&#46; Requena"
                            5 => "B&#46; Llombart"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermo-Sifiliogr&#225;ficas&#46;"
                        "fecha" => "2008"
                        "volumen" => "99"
                        "paginaInicial" => "281"
                        "paginaFinal" => "290"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18394404"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010700000001/v2_201704190205/S1578219015003145/v2_201704190205/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010700000001/v2_201704190205/S1578219015003145/v2_201704190205/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015003145?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 10 13 23
2024 October 85 55 140
2024 September 99 35 134
2024 August 128 91 219
2024 July 94 47 141
2024 June 92 56 148
2024 May 85 39 124
2024 April 110 33 143
2024 March 116 22 138
2024 February 107 32 139
2024 January 105 31 136
2023 December 90 37 127
2023 November 118 38 156
2023 October 123 45 168
2023 September 109 29 138
2023 August 71 17 88
2023 July 112 48 160
2023 June 74 30 104
2023 May 75 26 101
2023 April 90 32 122
2023 March 83 29 112
2023 February 65 32 97
2023 January 53 35 88
2022 December 80 56 136
2022 November 49 30 79
2022 October 42 22 64
2022 September 47 55 102
2022 August 29 52 81
2022 July 39 45 84
2022 June 46 41 87
2022 May 67 36 103
2022 April 59 37 96
2022 March 71 49 120
2022 February 53 42 95
2022 January 55 38 93
2021 December 47 35 82
2021 November 80 53 133
2021 October 65 51 116
2021 September 72 37 109
2021 August 58 26 84
2021 July 45 33 78
2021 June 53 32 85
2021 May 66 33 99
2021 April 98 26 124
2021 March 75 24 99
2021 February 69 34 103
2021 January 44 27 71
2020 December 36 21 57
2020 November 68 18 86
2020 October 72 14 86
2020 September 40 14 54
2020 August 30 23 53
2020 July 20 21 41
2020 June 42 27 69
2020 May 41 26 67
2020 April 34 16 50
2020 March 29 23 52
2020 February 2 3 5
2020 January 0 1 1
2019 December 0 1 1
2019 October 0 3 3
2019 May 2 2 4
2019 April 0 3 3
2019 March 0 5 5
2018 December 3 3 6
2018 November 3 0 3
2018 October 4 0 4
2018 September 7 2 9
2018 August 0 5 5
2018 July 0 3 3
2018 June 0 1 1
2018 May 0 3 3
2018 March 1 1 2
2018 February 40 6 46
2018 January 32 5 37
2017 December 47 12 59
2017 November 39 13 52
2017 October 32 19 51
2017 September 29 10 39
2017 August 30 9 39
2017 July 21 15 36
2017 June 40 11 51
2017 May 41 8 49
2017 April 34 11 45
2017 March 21 17 38
2017 February 37 8 45
2017 January 33 21 54
2016 December 39 33 72
2016 November 41 32 73
2016 October 34 31 65
2016 September 0 10 10
2016 August 0 8 8
2016 July 1 4 5
2016 June 0 3 3
2016 May 0 1 1
2016 April 0 3 3
2016 March 0 3 3
2016 February 0 11 11
2016 January 0 6 6
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?